Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study)

The quadrivalent human papillomavirus vaccine has been provided in Australia through the National Human Papillomavirus Vaccination Program since April 2007. National registry data demonstrates good coverage of the vaccine, with 73% of school-aged girls having received all three doses. To evaluate th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMC cancer 2013-06, Vol.13 (1), p.296-296, Article 296
Hauptverfasser:	Young, Elisa J, Tabrizi, Sepehr N, Brotherton, Julia Ml, Wark, John D, Pyman, Jan, Saville, Marion, Wrede, C David, Jayasinghe, Yasmin, Tan, Jeffrey, Gertig, Dorota M, Pitts, Marian, Garland, Suzanne M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Australia Biological products industry Cancer vaccines Cervical cancer Cervical Intraepithelial Neoplasia - prevention & control Cervical Intraepithelial Neoplasia - virology Female Genotype Health aspects Human papillomavirus Humans Papillomaviridae - genetics Papillomavirus Infections - prevention & control Papillomavirus Vaccines - therapeutic use Prevention Study Protocol Uterine Cervical Neoplasms - prevention & control Uterine Cervical Neoplasms - virology Vaccines Women Womens health Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!